Does DermTech (DMTK) have stellar fundamentals?
A positive signal came this week for DermTech Inc. (DMTK), a biotechnology company. DermaTech developed a new skin cancer diagnostic test, which a major insurance company has accepted. Cigna, which has approximately $90 billion in market cap, will cover the cost of DermTech tests through insurance programs. An easy-to-use test consists of simply glueing a […]
